Clinical Trials Browser

Terminated × Leukemia, Large Granular Lymphocytic × 1 year × Clear all

NCT05316116 2026-02-05

Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)

Phase EARLY_PHASE1 Terminated

Other hematologic neoplasm

Leukemia, Large Granular Lymphocytic